Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also referred to as FRAP-similar protein (FRP1)) has emerged as a promising strategy for cancer treatment method that exploits synthetic lethal interactions with proteins involved with DNA harm maintenance, overcomes resistance to other therapies and enhances antitumour immun... https://daglutril67990.jaiblogs.com/53574364/the-definitive-guide-to-tabilautide